In a filing, Akebia Therapeutics Inc. revealed its SVP, Chief Operating Officer Dahan Michel unloaded Company’s shares for reported $43898.0 on May 13 ’24. In the deal valued at $1.26 per share,34,840 shares were sold. As a result of this transaction, Dahan Michel now holds 672,092 shares worth roughly $0.77 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hadas Nicole R. sold 12,016 shares, generating $15,140 in total proceeds. Upon selling the shares at $1.26, the SVP, Chief Legal Officer now owns 651,243 shares.
Before that, Butler John P. sold 46,570 shares. Akebia Therapeutics Inc. shares valued at $73,581 were divested by the CEO and President at a price of $1.58 per share. As a result of the transaction, Butler John P. now holds 2,044,580 shares, worth roughly $2.33 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in late August from “a Neutral” to “a Buy”. Piper Sandler also remained covering AKBA and has increased its forecast on May 31, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Piper Sandler revised its rating on March 31, 2022. It rated AKBA as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of AKBA
On Monday, Akebia Therapeutics Inc. [NASDAQ:AKBA] saw its stock jump 1.79% to $1.14. Over the last five days, the stock has gained 3.64%. Akebia Therapeutics Inc. shares have fallen nearly -8.06% since the year began. Nevertheless, the stocks have risen 4.59% over the past one year. While a 52-week high of $2.48 was reached on 03/28/24, a 52-week low of $0.78 was recorded on 05/29/24. SMA at 50 days reached $1.3958, while 200 days put it at $1.2991. A total of 2.01 million shares were traded, compared to the trading of 2.11 million shares in the previous session.
Levels Of Support And Resistance For AKBA Stock
The 24-hour chart illustrates a support level at 1.1050, which if violated will result in even more drops to 1.0699. On the upside, there is a resistance level at 1.1801. A further resistance level may holdings at 1.2201. The Relative Strength Index (RSI) on the 14-day chart is 42.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0088, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.76%. Stochastics %K at 38.83% indicates the stock is a holding.
